689 related articles for article (PubMed ID: 17804716)
21. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
[TBL] [Abstract][Full Text] [Related]
22. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
Song SG; Yu HY; Ma YW; Zhang F; Xu XY
Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
[TBL] [Abstract][Full Text] [Related]
23. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
Lee HW; Kim SJ; Choi IJ; Song J; Chun KH
Clin Exp Metastasis; 2015 Aug; 32(6):593-603. PubMed ID: 26134677
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.
Lewis HD; Leveridge M; Strack PR; Haldon CD; O'neil J; Kim H; Madin A; Hannam JC; Look AT; Kohl N; Draetta G; Harrison T; Kerby JA; Shearman MS; Beher D
Chem Biol; 2007 Feb; 14(2):209-19. PubMed ID: 17317574
[TBL] [Abstract][Full Text] [Related]
25. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.
Konishi J; Yi F; Chen X; Vo H; Carbone DP; Dang TP
Oncogene; 2010 Jan; 29(4):589-96. PubMed ID: 19881544
[TBL] [Abstract][Full Text] [Related]
26. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.
Chu Q; Orr BA; Semenkow S; Bar EE; Eberhart CG
Clin Cancer Res; 2013 Jun; 19(12):3224-33. PubMed ID: 23630166
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design.
Wei P; Walls M; Qiu M; Ding R; Denlinger RH; Wong A; Tsaparikos K; Jani JP; Hosea N; Sands M; Randolph S; Smeal T
Mol Cancer Ther; 2010 Jun; 9(6):1618-28. PubMed ID: 20530712
[TBL] [Abstract][Full Text] [Related]
28. Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
Pine SR
Clin Cancer Res; 2018 Dec; 24(24):6136-6141. PubMed ID: 30104200
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
Nefedova Y; Gabrilovich D
Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
[TBL] [Abstract][Full Text] [Related]
30. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
32. Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation.
Vo K; Amarasinghe B; Washington K; Gonzalez A; Berlin J; Dang TP
Mol Cancer; 2011 Nov; 10():138. PubMed ID: 22074495
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of notch signaling induces neural differentiation in Ewing sarcoma.
Baliko F; Bright T; Poon R; Cohen B; Egan SE; Alman BA
Am J Pathol; 2007 May; 170(5):1686-94. PubMed ID: 17456774
[TBL] [Abstract][Full Text] [Related]
35. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
Stoeck A; Lejnine S; Truong A; Pan L; Wang H; Zang C; Yuan J; Ware C; MacLean J; Garrett-Engele PW; Kluk M; Laskey J; Haines BB; Moskaluk C; Zawel L; Fawell S; Gilliland G; Zhang T; Kremer BE; Knoechel B; Bernstein BE; Pear WS; Liu XS; Aster JC; Sathyanarayanan S
Cancer Discov; 2014 Oct; 4(10):1154-67. PubMed ID: 25104330
[TBL] [Abstract][Full Text] [Related]
36. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats.
Chen Y; Zheng S; Qi D; Zheng S; Guo J; Zhang S; Weng Z
PLoS One; 2012; 7(10):e46512. PubMed ID: 23056328
[TBL] [Abstract][Full Text] [Related]
39. Targeting Notch signaling as a novel therapy for retinoblastoma.
Asnaghi L; Tripathy A; Yang Q; Kaur H; Hanaford A; Yu W; Eberhart CG
Oncotarget; 2016 Oct; 7(43):70028-70044. PubMed ID: 27661116
[TBL] [Abstract][Full Text] [Related]
40. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
